ADR News Bulletin 2023 September (Volume 25 Number 2)
Bulletin Highlights:
- Reminder on the risk of pholcodine-associated perioperative anaphylaxis with neuromuscular blocking agents
- Biotin interference with thyroid function tests
- HSA is assessing the potential risk of suicidal thoughts and self-harm with glucagon-like peptide-1 receptor agonists (GLP-1 RA)
- Reports of issues associated with the use of Cathejell (lignocaine 2% gel)
Click on the link below to download the issue in pdf:
ADR_News_Sep2023_Vol25_No22340 KB
Healthcare professional, Industry member, Therapeutic Products
Published:
Adverse Drug Reaction News Bulletins
22 Sep 2023
Doctors, dentists and pharmacists can claim continuing education points for reading each issue of the HSA ADR News Bulletin. Doctors can apply for one non-core Continuing Medical Education (CME) point under category 3A, dentists can apply for one Continuing Professional Education (CPE) point under category 3A and pharmacists can apply for one patient-care Continuing Professional Education (CPE) point under category 3A per issue of the bulletin. Each issue of the bulletin is valid for two years.